News | April 19, 2026
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
The company allocated €56 million to research and development for next-generation line solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
Subscribe To Our Newsletter & Stay Updated
